Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This study is designed to demonstrate the non-inferiority and verify the safety of DWP14012-based triple therapy compared to DWC202301-based triple therapy as the first-line eradication therapy in patients who are positive for Helicobacter pylori
Epistemonikos ID: b09747b4797b5f8e666f53e37356430253a2835c
First added on: Jan 01, 2025